Effect of vitamin D on insulin sensitivity in elderly patients with impaired fasting glucose

Geriatrics and Gerontology International

Volumn 12, Issue 3, 2012, Pages 454-460

  Naharci, Ilkin ^a   Bozoglu, Ergun ^a   Kocak, Necmettin ^a   Doganci, Suat ^a   Doruk, Huseyin ^a   Serdar, Muhittin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Elderly; Impaired fasting glucose; Insulin sensitivity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM ION; COLECALCIFEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE SCORE; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; SCORING SYSTEM; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, HDL; MALE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; VITAMIN D;

EID: 84862693956     PISSN: 14441586     EISSN: 14470594     Source Type: Journal    
DOI: 10.1111/j.1447-0594.2011.00791.x     Document Type: Article

References (39)

1. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002; 162: 2269-2276.
2. Caughey GE, Ramsay EN, Vitry AI etal. Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. J Epidemiol Community Health 2010; 64: 1036-1042.
3. Røder ME, Schwartz RS, Prigeon RL, Kahn SE. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels. J Clin Endocrinol Metab 2000; 85: 2275-2280.
4. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose - a review of diagnosis, clinical implications and management. Diab Vasc Dis Res 2005; 2: 9-15.
5. Nathan DM, Davidson MB, DeFronzo RA etal. American Diabetes Association: impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 2007; 30: 753-759.
6. Kevorkian R. Physiology of aging. In: Pathy MSJ, Sinclair AJ, Morley JE, eds. Principles and Practice of Geriatric Medicine, 4th edn. Chichester, UK: John Wiley and Sons, 2006; 37-46.
7. Chang CI, Chan DC, Kuo KN, Hsiung CA, Chen CY. Vitamin D insufficiency and frailty syndrome in older adults living in a Northern Taiwan community. Arch Gerontol Geriatr 2010; 50: 17-21.
8. Audran M, Briot K. Critical reappraisal of vitamin D deficiency. Joint Bone Spine 2010; 77: 115-119.
9. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-1591.
10. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92: 2017-2029.
11. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813-2818.
12. Martini LA, Wood RJ. Vitamin D status and the metabolic syndrome. Nutr Rev 2006; 64: 479-486.
13. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinemia in elderly men. Diabetologia 1997; 40: 344-347.
14. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010; 103: 549-555.
15. Avenell A, Cook JA, MacLennan GS, McPherson GC. RECORD trial group. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2009; 38: 606-609.
16. Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Biol 2006; 92: 26-32.
17. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062-2072.
18. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
19. Sievenpiper JL, McIntyre EA, Verrill M, Quinton R, Pearce SHS. Unrecognized severe vitamin D deficiency. BMJ 2008; 336: 1371-1374.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
22. Kumar S, Olukoga AO, Gordon C etal. Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism. Clin Endocrinol 1994; 40: 47-53.
23. Chang E, Donkin SS, Teegarden D. Parathyroid hormone suppresses insulin signaling in adipocytes. Mol Cell Endocrinol 2009; 307: 77-82.
24. Billaudel BJ, Bourlon PM, Sutter BC, Faure-Dussert AG. Regulatory effect of 1, 25-dihydroxyvitamin D3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats. J Endocrinol Invest 1995; 18: 673-682.
25. Bourlon PM, Faure-Dussert A, Billaudel B. Modulatory role of 1, 25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat. Br J Pharmacol 1997; 121: 751-758.
26. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA. 1-alpha, 25-Dihydroxyvitamin D3 (1, 25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001; 145: 351-357.
27. Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and 1alpha, 25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005; 35: 217-224.
28. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003; 17: 509-511.
29. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1, 25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev 2008; 24: 459-464.
30. Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 1986; 119: 84-90.
31. Alvarez JA, Ashraf AP, Hunter GR, Gower BA. Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. Am J Clin Nutr 2010; 92: 1344-1349.
32. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28: 1228-1230.
33. Gupta AK, Brashear MM, Johnson WD. Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care 2011; 34: 658-660.
34. Stefíková K, Spustová V, Krivošíková Z etal. Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3. Physiol Res 2011; 60: 149-155.
35. Tzotzas T, Papadopoulou FG, Tziomalos K etal. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95: 4251-4257.
36. Rajpathak SN, Xue X, Wassertheil-Smoller S etal. Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative. Am J Clin Nutr 2010; 91: 894-899.
37. Major GC, Alarie F, Doré J, Phouttama S, Tremblay A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007; 85: 54-59.
38. Anderson JL, May HT, Horne BD etal. Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106: 963-968.
39. Zittermann A, Frisch S, Berthold HK etal. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89: 1321-1327.